Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
47 participants
INTERVENTIONAL
2012-02-29
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Changes in Adolescents While Imagining and Observing Aggressive Behavior
NCT00267891
Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents
NCT02563145
Brain Signal Training to Enhance Affect Down-regulation
NCT06626789
Neutral Correlates of Risk-taking in Adolescents Exposed to Drugs Prenatally
NCT01365988
Changes in the Brain as Borderline Patients Learn to Regulate Their Emotions
NCT02465697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Increase of synaptic 5-HT with a selective serotonin reuptake inhibitor (SSRI, Cipralex ®);
2. reduction of synaptic 5-HT with the Rapid Tryptophan Depletion Test (RTD); and 3) Placebo.
A blood sample genotyping will assess the allelic expression of the MAOA gene. We hypothesize
1. a modification of the ACC-amygdala system by the serotonergic intervention and
2. an interaction with the genotype concerning the MAOA gene. The results of this study will give valuable insights into the neurogenetic biology underlying aggression which will open new perspectives for therapeutical and pharmacological intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
arm 1
application of three treatments and three masurements within 3 weeks
cipralex
one time 10 mg, tablet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cipralex
one time 10 mg, tablet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18-60 (adults), age 12-17 (juveniles)
* right-handedness
* German native language
Exclusion Criteria
* any contraindications against application of SSRIs
* any history of neurological or psychiatric illness
* history of drug abuse
* history of psychopharmacological therapy
18 Years
60 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RWTH Aachen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital Aachen
Aachen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTC-A_12-023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.